Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
BMC Cancer
|
July 23, 2021
Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression
Stefano Mangiola, Patrick McCoy, Martin Modrak, et al.
Nature Immunology
|
August 1, 2017
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Yulong Gao, Fernando Souza-Fonseca-Guimaraes, Tobias Bald, et al.
Nature Immunology
|
January 5, 2024
IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development
Wilford Goh, Harrison Sudholz, Momeneh Foroutan, et al.
Nature Immunology
|
March 22, 2024
Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell
Yulong Gao, Fernando Souza-Fonseca-Guimaraes, Tobias Bald, et al.
Clinical & Translational Immunology
|
February 28, 2018
Rapid loss of group 1 innate lymphoid cells during blood stage <i>Plasmodium</i> infection
Susanna S Ng, Fernando Souza-Fonseca-Guimaraes, Fabian de Labastida Rivera, et al.
Blood Advances
|
June 8, 2021
BCL-XL antagonism selectively reduces neutrophil life span within inflamed tissues without causing neutropenia
Emma M Carrington, Cynthia Louis, Tobias Kratina, et al.
EMBO Molecular Medicine
|
January 24, 2024
Interferon-epsilon is a novel regulator of NK cell responses in the uterus
Jemma R Mayall, Jay C Horvat, Niamh E Mangan, et al.
Nature Immunology
|
August 24, 2021
Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity
Susan N Christo, Maximilien Evrard, Simone L Park, et al.
Nature Immunology
|
July 29, 2025
Lymph-node-derived stem-like but not tumor-tissue-resident CD8<sup>+</sup> T cells fuel anticancer immunity
Sharanya K M Wijesinghe, Lisa Rausch, Sarah S Gabriel, et al.
Cell Reports
|
October 9, 2024
Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity
Ethan P Oxley, Nadia J Kershaw, Cynthia Louis, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
BMC Cancer
|
July 23, 2021
Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression
Stefano Mangiola, Patrick McCoy, Martin Modrak, et al.
Nature Immunology
|
August 1, 2017
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Yulong Gao, Fernando Souza-Fonseca-Guimaraes, Tobias Bald, et al.
Nature Immunology
|
January 5, 2024
IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development
Wilford Goh, Harrison Sudholz, Momeneh Foroutan, et al.
Nature Immunology
|
March 22, 2024
Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell
Yulong Gao, Fernando Souza-Fonseca-Guimaraes, Tobias Bald, et al.
Clinical & Translational Immunology
|
February 28, 2018
Rapid loss of group 1 innate lymphoid cells during blood stage <i>Plasmodium</i> infection
Susanna S Ng, Fernando Souza-Fonseca-Guimaraes, Fabian de Labastida Rivera, et al.
Blood Advances
|
June 8, 2021
BCL-XL antagonism selectively reduces neutrophil life span within inflamed tissues without causing neutropenia
Emma M Carrington, Cynthia Louis, Tobias Kratina, et al.
EMBO Molecular Medicine
|
January 24, 2024
Interferon-epsilon is a novel regulator of NK cell responses in the uterus
Jemma R Mayall, Jay C Horvat, Niamh E Mangan, et al.
Nature Immunology
|
August 24, 2021
Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity
Susan N Christo, Maximilien Evrard, Simone L Park, et al.
Nature Immunology
|
July 29, 2025
Lymph-node-derived stem-like but not tumor-tissue-resident CD8<sup>+</sup> T cells fuel anticancer immunity
Sharanya K M Wijesinghe, Lisa Rausch, Sarah S Gabriel, et al.
Cell Reports
|
October 9, 2024
Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity
Ethan P Oxley, Nadia J Kershaw, Cynthia Louis, et al.
Page
of 14